Irish MedTech firm SymPhysis raises €1.9m to expand into the US market.

Galway based MedTech company SymPhysis has raised €1.9 million in funding to help it continue to develop its palliative care devices and enter the US market.

Three syndicates of Ireland’s Halo Business Angel Network (HBAN) – its MedTech Syndicate, Irrus Investments, and Boole Investment Syndicate – led the investment round. The MedTech received further finance from DBIC Ventures, Enterprise Ireland, and a private investor with experience in the palliative and home care markets.

SymPhysis Medical is creating a discreet drainage device called ‘releaze’ that is less invasive than competitor devices on the market and can be removed after only 30 days using revolutionary technology. The device takes a comprehensive approach to palliative care for cancer patients with a build-up of fluid in their chest, allowing them to care for themselves at home rather than being treated in a hospital.

Following FDA approval, the start-up intends to focus on the US market, with sales expected to reach €1.5 million in the first year, beginning at the end of 2023. By the end of 2025, the company hopes to have a turnover of €49 million.

We use cookies to give you the best online experience. By agreeing you consent the use of cookies in accordance with our Privacy Statement and cookie settings in your Privacy Settings below.

Privacy Settings saved!
Privacy Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie

Decline all Services
Accept all Services